ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of Pan-Vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00870636
Recruitment Status : Temporarily not available
First Posted : March 27, 2009
Last Update Posted : March 30, 2009
Sponsor:
Information provided by:
Children's Hospital Los Angeles

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Temporarily not available
  Primary Completion Date : No date given
  Study Completion Date : No date given